Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting

Author： Malessa R.   Gendolla A.   Steinberg B.   Schmitt L.   Bornhoevd K.   Djelani M.   Schäuble B.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.5, 2010-05, pp. : 1119-1129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open‐label, multi‐center trial

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1309-1315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24‐week, randomized, open‐label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape)

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 12, 2015-12 ,pp. : 1133-1141

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label, Randomized, Flexible-Dose, Crossover Study to Assess the Comparative Efficacy and Safety of Sildenafil Citrate and Apomorphine Hydrochloride in Men with Erectile Dysfunction

By  

Urologia Internationalis, Vol. 81, Iss. 4, 2008-12 ,pp. : 409-415

Karger

Access to resources Recommend Favorite

Resource utilization impact of topiramate for migraine prevention in the managed-care setting*

By Wertz Debra A.   Quimbo Ralph M.   Yaldo Avin Z.   Rupnow Marcia F. T.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 499-503

Informa Healthcare

Access to resources Recommend Favorite

Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB‐UVB vs. NB‐UVB alone in the treatment of vitiligo: a 24‐week prospective right–left comparative clinical trial

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 925-932

John Wiley & Sons Inc

Access to resources Recommend Favorite